From a laboratory at UCLA, a familiar supplement has revealed an unexpected role in the ancient struggle between the body and cancer. Researchers led by professor Lili Yang have found that creatine — long associated with athletic performance — appears to fortify the immune system's sentinel cells, helping them sustain their vigilance even within the nutrient-starved terrain that tumors create. The discovery does not promise a cure, but it quietly expands the horizon of what immunotherapy might one day achieve for the many patients it currently cannot reach.
UCLA researchers find creatine boosts immune cells that fight cancer
Cobertura Relacionada
Al menos 15 neonatos murieron en un incendio en un hospital de Islamabad, Pakistán. El siniestro ocurrió en una unidad d…
Business Empresarial · Aug 26 Mapfre lanza seguro sin límite de edad para adultos mayores con enfermedades preexistentesMapfre Perú presenta Salud Total, un seguro de salud diseñado para adultos mayores y personas con enfermedades preexiste…
Cadena SER · Aug 26 17.000 satélites orbitan sobre nuestras cabezas: la infraestructura invisible que sostiene el mundoIgnacio Crespo analiza cómo los 17.000 satélites en órbita son infraestructura crítica e insustituible para la sociedad …
Prensa Latina · Aug 26 China modernizará sistema de mercados agrícolas para 2030 con mayor conectividadChina aprobó un plan nacional para modernizar su sistema de mercados agrícolas de origen hacia 2030, mejorando la conexi…
Viés e Enquadramento
Não há dados de análise detalhada para esta lente. Tente executar as lentes novamente no painel de administração.
Impacto Geopolítico
UCLA cancer immunotherapy research has no direct geopolitical implications; this is a biomedical discovery with potential global health applications.
No power shifts. Potential future benefit: enhanced US biotech/pharmaceutical competitiveness if commercialized, but discovery is pre-clinical.
Lente Econômica
UCLA research shows creatine enhances immune cells fighting cancer, potentially improving immunotherapy effectiveness and creating market opportunities in supplements and cancer therapeutics.
Consumers may increase creatine supplementation purchases based on potential cancer-fighting benefits, though clinical applications remain in research phase. Could reduce out-of-pocket costs if incorporated into standard cancer treatment protocols, benefiting patients with limited access to expensive immunotherapies.
Regulatory bodies (FDA, EMA) may need to establish guidelines for creatine's medical use in cancer treatment. Potential reclassification from supplement to pharmaceutical ingredient. Insurance coverage policies may evolve to include creatine supplementation as adjunct therapy. Clinical trial acceleration likely for immunotherapy combinations.